Health and Fitness Health and Fitness
Thu, February 24, 2011

Inspire Announces Webcast of Presentation at Citi Global Healthcare Conference


Published on 2011-02-24 03:40:45 - Market Wire
  Print publication without navigation


RALEIGH, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Adrian Adams, President and CEO, will present at the Citi Global Healthcare Conference on Wednesday, March 2, 2011 at 10:30 am ET in New York City.

The webcast of the presentation will be available on Inspire's website at [ www.inspirepharm.com ]. An archived version of the webcast presentation will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a specialty pharmaceutical company focused on developing and commercializing ophthalmic products. Inspirea�s strategy is to create a sustainable portfolio of products by leveraging its commercial capabilities and pipeline assets and pursuing corporate development and licensing opportunities. Inspirea�s specialty eye care sales force generates revenue from the promotion of AZASITE (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis and the co-promotion of ELESTAT (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis. Inspire receives royalties based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% for dry eye and expects to begin receiving royalties in 2011 based on net sales of DIQUASa" Ophthalmic Solution 3% (diquafosol tetrasodium) for dry eye. For more information, visit [ www.inspirepharm.com ].